Concepedia

LC–MS/MS Quantification of Parathyroid Hormone Fragment 1–34 in Human Plasma

Robert MacNeill, Ryan Stromeyer, Bryan Urbanowicz, Vishva Acharya, Marc Moussallie

Bioanalysis · 2013 · 14 citations · 5 references

DOI

Abstract

All relevant acceptance criteria were met in a procedure akin to method validation without the stability aspects, and with a basis of excellent signal stability all performance aspects of the method were unassailable.

References

5

European Medicines Agency Guideline on Bioanalytical Method Validation: What More Is There to Say?

G. T. Smith · Bioanalysis · 2012 · 306 citations

, , +8

The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.

Donald B. Kimmel, Richard P. Bozzato, K. Anne Kronis et al. · Endocrinology · 1993 · 158 citations

, , +15

Bioanalytical Method Validation: Notable Points in The 2009 Draft EMA Guideline and Differences with The 2001 FDA Guidance

G. T. Smith · Bioanalysis · 2010 · 53 citations

, , +10

The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women

Sibylle P. Hämmerle, Linda Mindeholm, Aino Launonen et al. · Bone · 2012 · 43 citations

, , +9

Recombinant human parathyroid hormone 1–34: Pharmacokinetics, tissue distribution and excretion in rats

Zeping Hu, H NIU, Xi Yang et al. · International Journal of Pharmaceutics · 2006 · 20 citations

, , +5